Bromfenac Ophthalmic Solution 0.07% Versus Nepafenac Ophthalmic Suspension 0.3% for Post-Cataract Surgery Inflammation: A Pilot Study of Identical Dosing Regimens with Pre-Surgical “Pulse” Dose

INTRODUCTION: This small pilot study is the first direct comparison of the currently marketed formulations of bromfenac (0.07% solution) and nepafenac (0.3% suspension) using identical dosing regimens and including an extra pre-surgical “pulse” dose in patients undergoing cataract surgery. METHODS:...

Descripción completa

Detalles Bibliográficos
Autor principal: Silverstein, Steven M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858409/
https://www.ncbi.nlm.nih.gov/pubmed/31552543
http://dx.doi.org/10.1007/s40123-019-00215-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858409/
https://www.ncbi.nlm.nih.gov/pubmed/31552543
http://dx.doi.org/10.1007/s40123-019-00215-y

Ejemplares similares